30 closest matches · ranked by relevance
Hypercholesterolemia
Primary: Change From Baseline in Percent Atheroma Volume at Week 78 — 0.053; -0.955 percent atheroma volume — p=< 0.0001
Hypertriglyceridemia
Primary: Progression Rates of Low Attenuation Plaque Under Influence of Vascepa as Compared to Placebo as a Change Between Two or More Time Points — -0.3; 0.9 volume in mm cubed
Lipid Disorder
Primary: Low-density Lipoprotein Cholesterol (LDL-C) Levels at Baseline and Day 30 — 110; 84.0 mg/dL
Cardiovascular Diseases
Primary: Major Cardiovascular Disease Event — 3182; 527 Cardiovascular disease event
Cardiovascular Disease · Hypertension · Diabetes
Primary: Framingham Risk Percent (Estimate of 10 Year Risk of Cardiovascular Disease in Percent) — 32.4; 31.6 % 10 yr Risk
ASCVD · Elevated Cholesterol
Primary: Percentage Change in LDL-C From Baseline to Day 510 — -56.34; 1.30 percent change — p=<.0001
Surgical Wound
Primary: Time to Hemostasis (TTH) — 5.87 minutes
ASCVD · Risk Factor, Cardiovascular · Elevated Cholesterol
Primary: Percentage Change in LDL-C From Baseline to Day 510 — -49.3; 4.2 Percent change — p=<0.0001
Cardiovascular Disease · Hypertension · Hyperlipidemia
Primary: Changing LDL Cholesterol — 100; 70 Mg/dl
Cardiovascular Diseases · Myocardial Infarction · Atherosclerotic Cardiovascular Disease
Primary: Mean Fold Change in Brachial Vein Endothelial Inflammatory Transcript — 8.6; 2.8 Fold Change
Coronary Artery Disease · Carotid Artery Diseases · Atherosclerosis
Primary: Annualized LRNC Volume Change in Carotid Plaque Composition, as Assessed by MRI — -4.6; -15.1; -9.4 mm^3/year
Aortic Stenosis · Coronary Artery Disease
Primary: FFR 6 Months After SAVR/TAVI. — -0.0279 ratio
Coronary Atherosclerosis
Primary: Change From Baseline to End of Study (Week 104) in Percent Atheroma Volume (PAV) — -1.22; -0.99 Percent change
Carotid Atherosclerosis · Peripheral Arterial Disease
Primary: Measurement Bias of Calcification Analyzed by vascuCAP™ Non-invasively Relative to Histopathology as Ground Truth. — -0.47; .07 mm2
Cardiovascular Diseases
Primary: Step Counts — 48770 steps
Atherosclerotic Cardiovascular Disease · Familial Hypercholesterolemia · Diabetes
Primary: Percentage Change in LDL-C From Baseline to Day 180 — 2.1; -27.9; -38.4; -41.9 Percent change — p=<0.0001
Metabolic Syndrome X · Overweight · Hypertension
Primary: Change in Carotid Intima-media Thickness From Baseline to Year 1 — 0.766; 0.765; 0.758; 0.768 millmeter — p=0.7279
Cardiovascular Disease · Hypertension · Care Coordination
Primary: Mean Systolic Blood Pressure — 134.6; 133.3 mmHg
Hypercholesterolemia · Acute Coronary Syndrome
Primary: Percent Change From Baseline in Normalized Total Atheroma Volume (TAV) at Week 36 — -3.14; -4.79 percent change — p=0.2279
Hypercholesteremia
Primary: Percent Change From Baseline (Before the Start of Rosuvastatin Treatment) to Week 76 in the Plaque Volume (PV) — 14.1 Percent Change
HIV/AIDS · Cardiovascular Diseases
Primary: Number of Participants With Visit to a Cardiology Specialist From Cohort — 283 Participants
Spinal Cord Injuries · Heart Diseases
Primary: Percent Agreement Between Coronary Calcium Score (CCS) and National Cholesterol Education Program (NCEP) Guidelines — 18 percent agreement
Coronary Artery Disease, Hypercholesterolemia, Hypertension
Primary: Achievement Rate for Low Density Lipoprotein-Cholesterol (LDL-C) for Overall — 0.79; 0.67; 0.83; 0.57 Ratio
Dyslipidemia
Primary: Time to Cardiovascular Death, Myocardial Infarction, Hospitalization for Unstable Angina, Stroke, or Coronary Revascularization — 3.11; 2.74; 6.01; 5.31 percentage of…
Atherosclerosis · Cardiovascular Diseases · Hypercholesterolemia
Primary: First Occurrence of a Major Cardiovascular Event (MCE); Specifically Nonfatal Heart Attack, Nonfatal Stroke, or Cardiovascular Death (Measured Throughout the Study) in…
Hypercholesterolemia · Myocardial Infarction
Primary: Time to First Occurrence of Cardiovascular Death, Major Coronary Event, or Non-fatal Stroke (Kaplan-Meier Estimate of Percentage of Participants Experiencing a…
Acute Coronary Syndrome
Primary: Percent Change in LDL-Cholesterol — -68.78; -27.58 percent change
Cardiovascular Disease
Primary: Myocardial Perfusion Reserve — 2.76; 2.47; 2.82; 2.52 Ratio
Myocardial Infarction · Cardiovascular Disease
Primary: Major Cardiovascular Adverse Events (MACE) — 156; 118 number of adjudicated events — p=< 0.025
Atrial Fibrillation
Primary: Hemostasis — 9; 20; 7 minutes